MSATL2021

Multiple Sclerosis at the Limits 2021
Monday, 13 September – Tuesday, 14 September
Post Event Videos
Vaccines and infections and MS pt.1
Vaccine response in DMTs should be boosted
Dr Emma Tallantyre
Clinical Senior Lecturer, Division of Psychological Medicine and Clinical Neurosciences,
Cardiff University, UK
Intrathecal B-cell and CNS plasma cell biology in MS
Professor Robert P Lisak
Parker Webber Chair in Neurology; Professor of Neurology; Professor of Biochemistry, Microbiology and Immunology,
Wayne State University School of Medicine, Detroit, MI, USA
What is the antigenic target of the OCBs?
Dr Jeff Bennett
Neurologist, University of Colorado School of Medicine,
Colorado, USA
Diet and MS pt.1
Diet and MS course
Dr Ellen Mowry
Professor of Neurology and Epidemiology, Co-Director, Multiple Sclerosis Precision Medicine Center of Excellence,
Johns Hopkins University, Baltimore, MD, USA
Cortical lesion acquisition
Professor Massimiliano Calabrese
Professor of Neurology at Department of Neurosciences, Biomedicine and Movement at
University of Verona, Italy
The EClinical Medicine Lecture introduced by Derek Anane, Senior Editor: Targeting CNS plasma cells
Professor David Baker
Professor of Neuroimmunology,
Queen Mary University of London, UK
NMOSD pt.1
Long-term risk of infections and cancer with DMT
Dr Clemens Warnke
Consultant, Department of Neurology, Faculty of Medicine and University Hospital Cologne,
University of Cologne, Germany
NMOSD pt.2
The Lancet Lecture introduced by Dr Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology
Overview of NMOSD therapy
Dr Jacqueline Palace
Consultant Neurologist, University of Oxford Medical Sciences Division,
Oxford, UK
Diet and MS pt.2
Immunological effect of caloric restriction in MS and EAE
Dr Laura Piccio
Associate Professor, Department of Neurology, Washington University, St. Louis, MO, USA;
Associate Professor, The Brain and Mind Centre, University of Sydney, NSW, Australia
Round table discussion
Should we recommend HRT to perimenopausal women with MS?
Dr Louise R Newson (Newson Health, Stratford-Upon-Avon, UK)
Dr Ruth Dobson (Clinical Senior Lecturer in Neurology, Queen Mary University of London, UK)
Bonnie Boskovic (Patient Representative, UK)
Ageing and other factors in "Progression"
The effect of biological age on disease progression
Dr Jennifer Graves
Neurologist / Associate Professor of Neurosciences,
UC San Diego Health, San Diego, CA, USA
Use of NfL in ageing MS
Professor David Leppert
Professor of Neurology,
University Hospital Basel, Basel, Switzerland
Considerations for Covid vaccine in the era of early aggressive DMT
Professor Fredrik Piehl
Professor of Neurology,
The Karolinska Institute, Stockholm, Sweden
Vaccines and infections and MS pt.2
Vaccines: their effect on MS risk and course and their efficacy with DMT
Dr Christine Lebrun-Frenay
Head in Inflammatory Neurological Disorders Clinical Research Unit and MS Centre,
University of Nice Hospital, France
DMT discontinuation and initiation in older patients with MS
Dr John Corboy
Professor of Neurology,
University of Colorado School of Medicine, Denver, CO, USA

Support

The fixed costs of the meeting (Venue hire, AV, food & beverage, speaker fees etc.) are underwritten by Pharmaceutical Industry.